Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE Multicenter Trial

Fabrizio Oliva; Roberto Latini; Alessandro Politi; Lidia Staszewsky; Aldo Maggioni; Enrico Nicolis; Francesco Mauri

doi:10.1016/s0002-8703(99)70108-0

Related publications

Dataset

Faculty Opinions recommendation of Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial.

Giuseppe Remuzzi, Arrigo Schieppati

Article1988

Plasma infusion for hemolytic-uremic syndrome in children: Results of a multicenter controlled trial

Gianfranco Rizzoni, Aldo Claris-Appiani, Alberto Edefonti, Paola Facchin, F Franchinì, R Gusmano, E Imbasciati, Luigi Pavanello, Francesco Perfumo, Giuseppe Remuzzi

Article2010

Contractile Reserve in Segments With Nontransmural Infarction in Chronic Dysfunctional Myocardium Using Low-Dose Dobutamine CMR

Sharon W. Kirschbaum, Alexia Rossi, Ron T. van Domburg, Katerina Gruszczynska, Gabriël P. Krestin, Patrick W. Serruys, Dirk J. Duncker, Pim J. de Feyter, Robert‐Jan van Geuns

JACC. Cardiovascular imaging

Article2005

Cellular endotoxin desensitization in patients with severe chronic heart failure

Rakesh Kumar Sharma, Aidan P. Bolger, Mathias Rauchhaus, Stephan von Haehling, Wolfram Doehner, Ian M. Adcock, Peter J Barnes, Philip A. Poole‐Wilson, Hans‐Dieter Volk, Andrew J.S. Coats, Sam Lim, Stefan D. Anker

Article2011

Effect of Aliskiren in Patients with Heart Failure According to Background Dose of ACE Inhibitor: A Retrospective Analysis of the Aliskiren Observation of Heart Failure Treatment (ALOFT) Trial

Novalia Sidik, Scott D. Solomon, Roberto Latini, Aldo Maggioni, Melanie Wright, Claudio Gimpelewicz, Bertram Pitt, John J.V. McMurray